awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q51048811-2DBD6B8D-44C9-4177-88A3-9A5AF75FEA54
Q51048811-2DBD6B8D-44C9-4177-88A3-9A5AF75FEA54
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51048811-2DBD6B8D-44C9-4177-88A3-9A5AF75FEA54
Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum.
P2860
Q51048811-2DBD6B8D-44C9-4177-88A3-9A5AF75FEA54
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51048811-2DBD6B8D-44C9-4177-88A3-9A5AF75FEA54
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b3af0a52c74c7fcaeade996efa8b6786fc644c45
P2860
Administration of cetuximab every 2 weeks in the treatment of metastatic colorectal cancer: an effective, more convenient alternative to weekly administration?